Alimera Sciences Overview

Life ScienceCompany

Was Alimera Sciences formerly PE-backed?

Yes. Alimera Sciences was formerly owned by 1 private investor.

Where is Alimera Sciences headquartered?

Alimera Sciences is headquartered in Alpharetta, Georgia.

What is Alimera Sciences’ revenue?

Alimera Sciences disclosed revenue of 81M USD for 2023 and 54M USD for 2022.

What sector is Alimera Sciences in?

Alimera Sciences is a life science company.

When was Alimera Sciences founded?

Alimera Sciences was founded in 2003.

Alimera Sciences

Alimera Sciences, Inc.

6310 Town Square, Suite 400,
Alpharetta, Georgia 30005
United States,
(678) 990-5740
www.alimerasciences.com

Alimera Sciences is a biopharmaceutical company specializes in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. The company is focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies. Alimera Sciences was founded in 2003 and is based in Alpharetta, Georgia.



Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Alimera Sciences

Life Science Companies , United States Companies